Tjalma syndrome (pseudo-pseudo Meigs') as initial manifestation of juvenile-onset systemic lupus erythematosus
Reumatol Clin (Engl Ed). 2019 Sep-Oct;15(5):e41-e43.
doi: 10.1016/j.reuma.2017.04.003.
Epub 2017 May 15.
[Article in
English,
Spanish]
Affiliations
- 1 Reumatología Pediátrica, Hospital General, Centro Médico Nacional La Raza, IMSS, Ciudad de México, México. Electronic address: dr-poncho@hotmail.com.
- 2 Reumatología Pediátrica, Hospital General, Centro Médico Nacional La Raza, IMSS, Ciudad de México, México.
- 3 Cirugía Oncológica Pediátrica, Hospital General, Centro Médico Nacional La Raza, IMSS, Ciudad de México, México.
- 4 Hematología Pediátrica, Hospital General, Centro Médico Nacional La Raza, IMSS, Ciudad de México, México.
Abstract
Tjalma syndrome or pseudo-pseudo Meigs' syndrome is a clinical condition characterized by pleural effusion, ascites and elevated CA-125 with no associated benign or malignant ovarian tumor in a patient with systemic lupus erythematosus (SLE). Tjalma described the first case of a patient with SLE, pleural effusion, ascites and elevated CA-125. We report the first case in a 14-year old patient who presented with ascites and pleural effusion refractory to treatment and elevated CA-125, in the absence of an ovarian tumor, that warranted aggressive management.
Keywords:
CA-125; Lupus eritematoso sistémico; Pseudo-pseudo Meigs; Pseudo-pseudo Meigs’; Systemic lupus erythematosus; Síndrome de Tjalma; Tjalma syndrome.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.
MeSH terms
-
Acute Kidney Injury
-
Adolescent
-
Ascites / therapy
-
CA-125 Antigen / blood
-
Cyclophosphamide / therapeutic use
-
Female
-
Humans
-
Lupus Erythematosus, Systemic / complications*
-
Meigs Syndrome / diagnosis
-
Meigs Syndrome / drug therapy
-
Meigs Syndrome / etiology*
-
Paracentesis
-
Pleural Effusion / etiology
-
Purpura, Thrombotic Thrombocytopenic / therapy
-
Rituximab / therapeutic use
Substances
-
CA-125 Antigen
-
Rituximab
-
Cyclophosphamide